SNY and TBIO buttoned up the news this morning sending a bunch of other biotech stocks running higher. Now that this is out of the way, levels could be important for longs looking for "what's next" and the 236 Fib level seems to be that area to watch. It was an area that the volatile SNY stock settled above for weeks and now is an area it hasn't been able to...
Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, as of 2013 the world's fifth-largest by prescription sales. Shown here is the daily chart, with monthly zones/lines of support (green dashed lines) and resistance (red dashed lines). Also shown is a Fibonacci drawn on the monthly chart. In the 4H, Sanofi is clearly bullish...
Moderna is the first company to start the phase 3 trial in July and could have the supply ready earliest by Oct and accelerated approval earliest by December, according to Nami Sumida/BioPharma Dive and morningstar.
Other competitors are scheduled to have accelerated approval the earliest around early 2021.
Sanofi is leading the clinical development and registration of the COVID-19 vaccine and expects a Phase 1/ 2 study to start in September, followed by a Phase 3 study by the end of 2020. If data are positive, regulatory approval could be achieved by the first half of 2021. In parallel, Sanofi and GSK are scaling up manufacturing of the antigen and adjuvant to...
The price has been ranging widely, coming back to its pre-pandemic trend.
The price is coming very closely to two different important "pullback up" line.
Probability of nice entry for a long direction trade.
In the flip side, if it breaks down those two lines further, there is a risk to see the price approaching the horizontal black line.
For the moment, the...
NASDAQ:SNY is showing signs that it is heading up to around the 54.5 area .There is a possibility that It could return back to around the 48 area and then bounce back from there to around the 54.5 area but I think price would rather break significantly above the 50 until around the 54-55 area .
SNY has experience two bump and runs throughout the course of its listing. Will a third follow? If so will it be immediately or will further trend strengthening occur. The bump and runs also resulted in two triple tops.
Possible Volatility contraction pattern 3T observed.
Price getting support from pivot zones.
Pivot based emas started spreading out indicating possibility of price moving up.